SBTX   $5.87  0.52% Market Closed

Silverback Therapeutics Inc
Total Cash 266.62M
totalCashPerShare 7.519
EBITDA -85.90M
Total Debt 215.00K
quickRatio 66.823
currentRatio 67.869
Total Revenue
debtToEquity 0.081
Revenue/Share
ROA -0.17363001
ROE -0.28499
grossProfits
freeCashflow -59.46M
operatingCashflow -72.78M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -58.27M
forwardPE -2.7558684
floatShares 22.45M
sharesOutstanding 36.06M
sharesShort 897.57K
sharesShortPriorMonth 542.96K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.79%
Short Ratio help_outline 5.20%
shortPercentOfFloat 0.04%
impliedSharesOutstanding 0.00
bookValue 7.532
Price To Book help_outline 0.78
earningsQuarterlyGrowth
netIncomeToCommon -85.71M
trailingEps -2.73%
forwardEps -2.13%
enterpriseToEbitda 0.68
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.34 4Q 2022
institutionsCount 92
lastUpdated Jan. 10, 2023, 11:25 a.m.